BOSTON, Sept. 30, 2024 -- Aktis Oncology, a clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today...
Pappas Ventures names Michael Grey Venture Partner
News | 01. 11. 2010
Pappas Ventures today announced that industry veteran Michael Grey has been named a venture partner.
